Prestige Consumer Healthcare (PBH) Inventory (2011 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Inventory came in at $163.6 million in Q4 2025, up 7.97% year-on-year from $151.5 million in Q4 2024, and up 2.89% quarter-over-quarter from $159.0 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Inventory (2011 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Inventory history runs 15 years deep, the most recent figure standing at $163.6 million for Q4 2025.
- On a quarterly basis, Inventory rose 7.97% year-over-year to $163.6 million in Q4 2025; TTM through Dec 2025 was $163.6 million, a 7.97% increase from a year earlier, with the FY2025 full-year figure at $147.7 million, up 6.48% from the prior year.
- Inventory advanced to $163.6 million in Q4 2025 per PBH's latest filing, from $159.0 million in the prior quarter.
- Across five years, Inventory topped out at $169.8 million in Q2 2023 and bottomed at $105.5 million in Q2 2021.
- The 5-year median for Inventory is $150.1 million (2023), against an average of $142.6 million.
- Across the five-year window, Inventory jumped 49.16% in 2022 and dropped 14.44% in 2024, its largest moves.
- Year by year, Inventory stood at $106.3 million in 2021, then soared by 49.16% to $158.5 million in 2022, then declined by 6.24% to $148.6 million in 2023, then advanced by 1.94% to $151.5 million in 2024, then climbed by 7.97% to $163.6 million in 2025.
- Per Business Quant, the three latest PBH Inventory figures stand at $163.6 million (Q4 2025), $159.0 million (Q3 2025), and $153.1 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.36 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.18 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.55 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 8.91 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 178.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.49 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.93 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 64.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.72 Bn |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn | 163.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 163.59 Mn |
| Sep 30, 2025 | 159.00 Mn |
| Jun 30, 2025 | 153.13 Mn |
| Mar 31, 2025 | 147.71 Mn |
| Dec 31, 2024 | 151.52 Mn |
| Sep 30, 2024 | 156.23 Mn |
| Jun 30, 2024 | 152.04 Mn |
| Mar 31, 2024 | 138.72 Mn |
| Dec 31, 2023 | 148.64 Mn |
| Sep 30, 2023 | 161.28 Mn |
| Jun 30, 2023 | 169.85 Mn |
| Mar 31, 2023 | 162.12 Mn |
| Dec 31, 2022 | 158.52 Mn |
| Sep 30, 2022 | 140.51 Mn |
| Jun 30, 2022 | 133.77 Mn |
| Mar 31, 2022 | 120.34 Mn |
| Dec 31, 2021 | 106.27 Mn |
| Sep 30, 2021 | 107.92 Mn |
| Jun 30, 2021 | 105.55 Mn |
| Mar 31, 2021 | 114.96 Mn |